isoproterenol has been researched along with cilazapril, anhydrous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Clozel, JP; Fischli, W; Kuhn, H; Roux, S | 1 |
Beretta-Piccoli, C; Bernasconi, M; Lepori, G; Marone, C; Shaw, S; Weidmann, P | 1 |
Belz, GG; Essig, J; Hoogkamer, JF; Kleinbloesem, CH; Wellstein, A; Wiegand, UW | 1 |
1 trial(s) available for isoproterenol and cilazapril, anhydrous
Article | Year |
---|---|
Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Norepinephrine; Pressoreceptors; Propranolol; Pyridazines; Renin; Renin-Angiotensin System; Time Factors | 1988 |
3 other study(ies) available for isoproterenol and cilazapril, anhydrous
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Isoproterenol impairs the rat coronary vasculature: effects of angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Coronary Circulation; Coronary Vessels; Female; Heart; Heart Rate; Isoproterenol; Male; Organ Size; Pyridazines; Rats; Renin; Renin-Angiotensin System | 1992 |
Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cilazapril; Female; Humans; Isoproterenol; Male; Middle Aged; Pyridazines; Renin-Angiotensin System; Sympathetic Nervous System | 1991 |